Literature DB >> 33303677

High Salt Intake Recruits Tonic Activation of NR2D Subunit-Containing Extrasynaptic NMDARs in Vasopressin Neurons.

Chiranjivi Neupane1,2, Ramesh Sharma1,2, Yoon Hyung Pai1, So Yeong Lee3, Byeong Hwa Jeon1,2, Hyun-Woo Kim1,2, Javier E Stern4, Jin Bong Park5,2.   

Abstract

In addition to producing a classical excitatory postsynaptic current via activation of synaptic NMDA receptors (NMDARs), glutamate in the brain also induces a tonic NMDAR current (I NMDA) via activation of extrasynaptic NMDARs (eNMDARs). However, since Mg2+ blocks NMDARs in nondepolarized neurons, the potential contribution of eNMDARs to the overall neuronal excitatory/inhibitory (E/I) balance remains unknown. Here, we demonstrate that chronic (7 d) salt loading (SL) recruited NR2D subunit-containing NMDARs to generate an Mg2+-resistant tonic I NMDA in nondepolarized [V h (holding potential) -70 mV] vasopressin (VP; but not oxytocin) supraoptic nucleus (SON) neurons in male rodents. Conversely, in euhydrated (EU) and 3 d SL mice, Mg2+-resistant tonic I NMDA was not observed. Pharmacological and genetic intervention of NR2D subunits blocked the Mg2+-resistant tonic I NMDA in VP neurons under SL conditions, while an NR2B antagonist unveiled Mg2+-sensitive tonic I NMDA but not Mg2+-resistant tonic I NMDA In the EU group VP neurons, an Mg2+-resistant tonic I NMDA was not generated by increased ambient glutamate or treatment with coagonists (e.g., d-serine and glycine). Chronic SL significantly increased NR2D expression but not NR2B expression in the SON relative to the EU group or after 3 d under SL conditions. Finally, Mg2+-resistant tonic I NMDA selectively upregulated neuronal excitability in VP neurons under SL conditions, independent of ionotropic GABAergic input. Our results indicate that the activation of NR2D-containing NMDARs constitutes a novel mechanism that generates an Mg2+-resistant tonic I NMDA in nondepolarized VP neurons, thus causing an E/I balance shift in VP neurons to compensate for the hormonal demands imposed by a chronic osmotic challenge.SIGNIFICANCE STATEMENT The hypothalamic supraoptic nucleus (SON) consists of two different types of magnocellular neurosecretory cells (MNCs) that synthesize and release the following two peptide hormones: vasopressin (VP), which is necessary for regulation of fluid homeostasis; and oxytocin (OT), which plays a major role in lactation and parturition. NMDA receptors (NMDARs) play important roles in shaping neuronal firing patterns and hormone release from the SON MNCs in response to various physiological challenges. Our results show that prolonged (7 d) salt loading generated a Mg2+-resistant tonic NMDA current mediated by NR2D subunit-containing receptors, which efficiently activated nondepolarized VP (but not OT) neurons. Our findings support the hypothesis that NR2D subunit-containing NMDARs play an important adaptive role in adult brain in response to a sustained osmotic challenge.
Copyright © 2021 the authors.

Entities:  

Keywords:  NR2D; iMK801; oxytocin; salt loading; tonic NMDA; vasopressin

Year:  2020        PMID: 33303677      PMCID: PMC7888215          DOI: 10.1523/JNEUROSCI.1742-20.2020

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  73 in total

1.  Developmental changes in distribution of NMDA receptor channel subunit mRNAs.

Authors:  M Watanabe; Y Inoue; K Sakimura; M Mishina
Journal:  Neuroreport       Date:  1992-12       Impact factor: 1.837

2.  Characterization of a novel tonic gamma-aminobutyric acidA receptor-mediated inhibition in magnocellular neurosecretory neurons and its modulation by glia.

Authors:  Jin Bong Park; Silvia Skalska; Javier E Stern
Journal:  Endocrinology       Date:  2006-05-04       Impact factor: 4.736

Review 3.  Neurophysiology and neuropharmacology of hypothalamic magnocellular neurons secreting vasopressin and oxytocin.

Authors:  L P Renaud; C W Bourque
Journal:  Prog Neurobiol       Date:  1991       Impact factor: 11.685

4.  N-terminal domains in the NR2 subunit control desensitization of NMDA receptors.

Authors:  J J Krupp; B Vissel; S F Heinemann; G L Westbrook
Journal:  Neuron       Date:  1998-02       Impact factor: 17.173

5.  Ultrastructural changes in rat hypothalamic neurosecretory cells and their associated glia during minimal dehydration and rehydration.

Authors:  C D Tweedle; G I Hatton
Journal:  Cell Tissue Res       Date:  1977-06-20       Impact factor: 5.249

6.  Synaptic and extrasynaptic NMDA receptors are gated by different endogenous coagonists.

Authors:  Thomas Papouin; Laurent Ladépêche; Jérôme Ruel; Silvia Sacchi; Marilyne Labasque; Marwa Hanini; Laurent Groc; Loredano Pollegioni; Jean-Pierre Mothet; Stéphane H R Oliet
Journal:  Cell       Date:  2012-08-03       Impact factor: 41.582

7.  Single cell analysis of voltage-gated potassium channels that determines neuronal types of rat hypothalamic paraventricular nucleus neurons.

Authors:  S K Lee; S Lee; S Y Shin; P D Ryu; S Y Lee
Journal:  Neuroscience       Date:  2012-01-05       Impact factor: 3.590

8.  Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells.

Authors:  I Bresink; T A Benke; V J Collett; A J Seal; C G Parsons; J M Henley; G L Collingridge
Journal:  Br J Pharmacol       Date:  1996-09       Impact factor: 8.739

9.  Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways.

Authors:  G E Hardingham; Y Fukunaga; H Bading
Journal:  Nat Neurosci       Date:  2002-05       Impact factor: 24.884

Review 10.  Influence of GluN2 subunit identity on NMDA receptor function.

Authors:  D J A Wyllie; M R Livesey; G E Hardingham
Journal:  Neuropharmacology       Date:  2013-01-31       Impact factor: 5.250

View more
  1 in total

1.  NMDA Receptors in the Lateral Preoptic Hypothalamus Are Essential for Sustaining NREM and REM Sleep.

Authors:  Giulia Miracca; Berta Anuncibay-Soto; Kyoko Tossell; Raquel Yustos; Alexei L Vyssotski; Nicholas P Franks; William Wisden
Journal:  J Neurosci       Date:  2022-06-01       Impact factor: 6.709

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.